A Model to Account for the Blood-to-Plasma Distribution of Cyclosporin A in Human Blood
スポンサーリンク
概要
- 論文の詳細を見る
A mathematical model to account for the blood-to-plasma distribution of cyclosporin A (CyA) in human blood was derived, and alterations in the blood-to-plasma distribution of CyA under several influencing conditions were examined using this model. The model was derived on the assumption that there are two CyA binding sites in human blood, which exist in plasma and cellular fractions. In the plasma fraction, the CyA binding sites are mainly lipoproteins (LPs), in which CyA exhibits nonsaturable, low affinity binding with LPs independent of drug concentration. In the cellular fraction, the binding site of CyA is the CyA binding protein (CBP), in which CyA shows a specific binding in a temperature dependent, saturable process. The results obtained from simulative studies agreed with previous reports on the blood-to-plasma distribution of CyA, indicating the usefulness of this approach. And also, this model may be used to predetermine individual variations in the blood-to-plasma distribution of the drug in renal transplant patients.
- 公益社団法人日本薬学会の論文
著者
-
Ono Takeshi
Hospital Pharmacy Shiga University Of Medical Science
-
Sugioka Nobuyuki
Dep. Of Pharmacokinetics Kyoto Pharmaceutical Univ.
-
Shimakawa H
Shiga Univ. Medical Science
-
Shibata Nobuhito
Dep. Of Pharmacokinetics Kyoto Pharmaceutical Univ.
-
SHIMAKAWA Harumi
Hospital Pharmacy, Shiga University of Medical Science
-
SHIBATA Nobuhito
Hospital Pharmacy, Shiga University of Medical Science
-
MINOUCHI Tokuzo
Hospital Pharmacy, Shiga University of Medical Science
-
Minouchi T
Department Of Hospital Pharmacy Of Shiga University Of Medical Science
-
Minouchi Tokuzo
Hospital Pharmacy Shiga University Of Medical Science
-
Shimakawa Harumi
Hospital Pharmacy Shiga University Of Medical Science
-
Shibata Nobuhito
Hospital Pharmacy Shiga University Of Medical Science
関連論文
- Pharmacokinetics of Human Immunodeficiency Virus Protease Inhibitor, Nelfinavir, in Poloxamer 407-Induced Hyperlipidemic Model Rats(Biopharmacy)
- ENHANCING EFFECT OF ABSORPTION PROMOTERS ON PERCUTANEOUS ABSORPTION OF A MODEL DYE (6-CARBOXYFLUORESCEIN) AS A POORLY ABBSORBABLE DRUG. III.^ HISTOLOGICAL STUDY AFTER ADDITION OF VARIOUS ABSORPTION PROMOTERS IN RATS
- EFFECT OF ADMINISTRATION ROUTE ON THE SELECTIVE LYMPHATIC DELIVERY OF CYCLOSPORIN A BY LIPID-SURFACTANT MIXED MICELLES
- ENHANCING EFFECT OF ABSORPTION PROMOTERS ON PERCUTANEOUS ABSORPTION OF A MODEL DYE (6-CARBOXYFLUORESCEIN) AS POORLY ABSORBABLE DRUGS. II. STUDY ON THE ABSORPTION PROMOTING EFFECT OF AZONE
- PROMOTION OF THE SELECTIVE LYMPHATIC DELIVERY OF CYCLOSPORIN A BY LIPID-SURFACTANT MIXED MICELLES
- ENHANCING EFFECT OF ABSORPTION PROMOTERS ON PERCUTANEOUS ABSORPTION OF A MODEL DYE (6-CARBOXYFLUORESCEIN) AS POORLY ABSORBABLE DRUGS. I. COMPARISON OF PLASMA LEVELS AFTER ADDITION OF VARIOUS ABSORPTION PROMOTERS IN RAT
- Evaluation of Gastrointestinal Transit Characteristics of Oral Patch Preparation Using Caffeine as a Model Drug in Human Volunteers
- Pharmaceutical Approach to HIV Protease Inhibitor Atazanavir for Bioavailability Enhancement Based on Solid Dispersion System(Biopharmacy)
- Fluctuation in Therapeutic Control Associated with Interchange of Prednisolone Tablet Formulations : Assessment of Bioequivalence by Dissolution Test
- Evaluation of Factors to Decrease Bioavailability of Cyclosporin A in Rats with Gentamicin-Induced Acute Renal Failure (Biopharmacy)
- Effect of Indinavir on the Intestinal Exsorption of Amprenavir, Saquinavir and Nelfinavir after Intravenous Administration in Rats
- Pharmacokinetic Behavior of Micafungin in Rats with Carbon Tetrachloride-Induced Acute Hepatic Failure(Biopharmacy)
- Simultaneous determination of glucocorticoids in plasma or urine by high-performance liquid chromatography with precolumn fluorimetric derivatization by 9-anthroyl nitrile
- A Predictive Model for Area Under the Concentration versus Time Curve of Cyclosporin A Using Several Routine Monitoring Results in Renal Transplant Patients
- Evaluation of Factors to Decrease Plasma Concentration of an HIV Protease Inhibitor, Saquinavir in Ethanol-Treated Rats(Biopharmacy)
- Highly sensitive quantification of vancomycin in plasma samples using liquid chromatography-tandem mass spectrometry and oral bioavailability in rats
- Relationship between Excretion Clearance of Rhodamine 123 and P-Glycoprotein (Pgp) Expression Induced by Representative Pgp Inducers(Biopharmacy)
- In Vivo Effects of Cyclosporin A and Ketoconazole on the Pharmacokinetics of Representative Substrates for P-Glycoprotein and Cytochrome P450 (CYP) 3A in Rats(Biopharmacy)
- Effect of Chronic Administration of Ritonavir on Function of Cytochrome P450 3A and P-Glycoprotein in Rats(Biopharmacy)
- Clinical Pharmacokinetics of Mycophenolate Mofetil in Japanese Renal Transplant Recipients : a Retrospective Cohort Study in a Single Center(Biopharmacy)
- Self-Dissolving Micropiles for the Percutaneous Absorption of Recombinant Human Growth Hormone in Rats(Biopharmacy)
- Long-Term Pharmacokinetic Efficacy and Safety of Low-Dose Ritonavir as a Booster and Atazanavir Pharmaceutical Formulation Based on Solid Dispersion System in Rats(Biopharmacy)
- Antihyperglycemic Effect of Insulin from Self-Dissolving Micropiles in Dogs
- Effect of Water Intake on Pharmacokinetics of Lansoprazole from Fast Disintegrating Tablet in Human Subjects
- Evaluation of Carbamazepine Pharmacokinetic Profiles in Mice with Kainic Acid-Induced Acute Seizures(Miscellaneous)
- Effect of Glycerol-Induced Acute Renal Failure on the Pharmacokinetics of Lidocaine after Transdermal Application in Rats(Biopharmacy)
- Evaluation of Gastrointestinal Mucoadhesive Patch System (GI-MAPS) Containing Caffeine as a Model Drug in Human Volunteers
- Inhibition of Testosterone Biosynthesis in Testicular Microsomes by Various Imidazole Drugs. Comparative Study with Ketoconazole
- A Model to Account for the Blood-to-Plasma Distribution of Cyclosporin A in Human Blood
- Effects of Antimycotics on Hepatic Steroid Metabolism
- Effects of Ozagrel (OKY-046), a Thromboxane Synthase Inhibitor, on Oxidative Drug-Metabolizing Enzymes in Mouse Hepatic Microsomes
- Effects of Diltiazem on Rheological Properties of Human Blood
- Inhibitory Effects of Ketoconazole and Miconazole on Cytochrome P-450-Mediated Oxidative Metabolism of Testosterone and Xenobiotics in Mouse Hepatic Microsomes-Comparative Study with Cimetidine
- A COMPARISON OF THE INHIBITORY EFFECTS OF ROXATIDINE ACETATE HYDROCHLORIDE AND CIMETIDINE ON CYTOCHROME P-450-MEDIATED DRUG-METABOLISM IN MOUSE HEPATIC MICROSOMES AND IN MAN IN VIVO
- Selective Inhibition of Hepatic Microsomal Drug-Metabolism by Mexiletine Hydrochloride
- Retrospective Pharmacokinetic Data Analysis of Cyclosporin A Using Routine Monitoring Data in Renal Transplant Patients : Consideration on Its Pharmacokinetic Profiles and Physiological Factors during Renal Dysfunction
- Evaluation of fluorescence polarization immunoassay for determination of cyclosporin in whole blood and its clinical relevance.